Pharmacy Ownership

In accordance with the Pharmacy Act, 2024, the Pharmacy Regulations, 2024, and the CPNL Bylaws, all current and proposed pharmacy owners must provide information, documentation, and declarations to the College of Pharmacy of Newfoundland and Labrador (CPNL) to own a pharmacy.

Pharmacy Owners

Required Documentation

The three classifications of pharmacy ownership are a corporation1, a partnership2, and individual ownership through a sole proprietorship3. The information and documentation requirements for each pharmacy ownership classification are listed below.

Designated Representatives

All pharmacy owners that are corporations or partnerships must appoint a designated representative; where the pharmacy owner is a sole proprietor, the sole proprietor is deemed the designated representative.

The designated representative of a pharmacy owner is an individual authorized by the pharmacy owner to:

accept delivery of correspondence and other notices or documents on behalf of the pharmacy owner;
make declarations on behalf of the pharmacy owner; and
act on behalf of the pharmacy owner in all dealings with CPNL.

Required Documentation

The information and documentation requirements for the designated representative are listed below:

name;
address;
telephone number;
email address;
where the pharmacy owner is a corporation or partnership:
a description of the designated representative’s relationship to the corporation or partnership (e.g., director, partner);
written documentation that the designated representative is authorized to act, sign declarations, and accept correspondence on behalf of the corporation or partnership;
must be on the letterhead of the corporation or partnership
must include a statement that: “[Designated Representative Name] is authorized to act on behalf of [Corporation/Partnership Name] in all dealings with the College of Pharmacy of Newfoundland and Labrador, to accept delivery of correspondence and other notices or documents on behalf of [Corporation/Partnership Name], and to sign declarations on behalf of [Corporation/Partnership Name];
for corporations, the letter must be signed by an individual with signing authority on behalf of the corporation, and for partnerships, the letter must be signed by all partners.
an undertaking of responsibility to deliver all correspondence, notices, or other documents issued to the attention of the corporation or partnership accurately and promptly upon receipt.
a certificate of conduct in accordance with CPNL’s Certificate of Conduct Requirements;
declarations of the designated representative and declarations on behalf of the pharmacy owner.

FAQ

Collection of Information

Ownership Structure

Designated Representative

Additional Resources

Pharmacy Owner Information Interpretation Guide
Pharmacy Owner Information Form: Corporation or Partnership
Designated Representative Information and Declarations Form: Corporation or Partnership
Designated Representative Information and Declarations Form: Sole Proprietor
  1. “Corporation” means a body corporate incorporated or continued under the Newfoundland and Labrador Corporations Act. It is an entity separate and distinct from its shareholders. Corporations may be non-publicly traded, publicly traded, or incorporated by legislation (e.g., hospital pharmacies). ↩︎
  2. “Partnership” means the relationship that exists between persons carrying on a business in common with a view to make profit, pursuant to the Newfoundland and Labrador (NL) Partnership Act, but does not include the relation between members of a company or association that is registered as a company or incorporated under the Corporations Act or other NL legislation. ↩︎
  3. “Sole proprietor” means an individual who owns and runs an unincorporated business. ↩︎
  4. “Non-publicly traded corporation” means a corporation whose shares are privately held and not listed on a public stock exchange. ↩︎
  5. See “individual with significant control over a corporation” in section 45.1 of the Newfoundland and Labrador Corporations Act. ↩︎
  6. See “individual” in section 2(5)(b) of the Pharmacy Regulations, 2024 ↩︎

Scroll to Top